Advertisement

Acceptance and Feasibility of Partner Notification to HIV Infected Individuals in Guinea-Bissau

  • Tina MadsenEmail author
  • Sanne Jespersen
  • Candida Medina
  • David D. S. Té
  • Christian Wejse
  • Alex L. Laursen
  • Bo L. Hønge
  • for the Bissau HIV Cohort Study Group
Original Paper
  • 2 Downloads

Abstract

As partner notification (PN) has shown effective in increasing the number of partners of HIV infected patients being tested we aimed to evaluate the feasibility of implementing PN in the West-African country Guinea-Bissau. Patients enrolled were offered the choice of three different PN methods. Acceptance, successful referrals and HIV status of partners were evaluated. Of 697 patients offered PN, 495 (71.0%) accepted and listed 547 partners. At end of follow-up 118 (21.5%) partners had been tested of which 44 (37.3%) were HIV infected. HIV infected partners had a higher median CD4 count at diagnosis compared with index patients; 401 cells/mm3 versus 240 cells/mm3, p < 0.001. The results indicate that implementation of PN is feasible, effective in identifying HIV infected partners and enables initiation of earlier treatment, yet there are major barriers to bringing partners in for testing which should be addressed in order to exploit the full potential of PN.

Keywords

Partner notification Contact tracing HIV Sub-Saharan Africa Guinea-Bissau 

Notes

Acknowledgements

The authors are grateful to the staff working at the CTA HNSM, especially the psychologists Juelma, Anilde and Victoriana who put a lot of work and effort into locating partners. We would also like to thank the office staff at the Bandim Health Project without whom this study would not have been possible. A special thanks to UNICEF in Guinea-Bissau for their cooperation and support throughout the period of the study. The Bissau HIV cohort study group comprises: Amabelia Rodrigues, David da Silva Té, Zacarias da Silva, Candida Medina, Ines Oliviera-Souto, Lars Østergaard, Alex Lund Laursen, Peter Aaby, Anders Fomsgaard, Christian Erikstrup, Bo Langhoff Hønge, Christian Wejse and Sanne Jespersen (chair).

Funding

This study was funded by UNICEF Guinea-Bissau, The Independent Research Fund Denmark (scholarship for TM), Kong Christian X’s Fond, Fonden til Lægevidenskabens Fremme and Agnethe Løvgreens Legat.

Compliance with Ethical Standards

Conflict of interest

The authors have no competing interest to declare.

References

  1. 1.
    UNAIDS. Prevention Gap Report 2016 [Internet]. http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf. Accessed 8 May 2018.
  2. 2.
    Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.CrossRefGoogle Scholar
  3. 3.
    Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010;3:CD008272.Google Scholar
  4. 4.
    INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRefGoogle Scholar
  5. 5.
    Hønge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva Té D, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau—a cohort study from West Africa. Pan Afr Med J. 2016;25:40.CrossRefGoogle Scholar
  6. 6.
    Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.CrossRefGoogle Scholar
  7. 7.
    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.CrossRefGoogle Scholar
  8. 8.
    Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS Lond Engl. 2009;23(11):1397–404.CrossRefGoogle Scholar
  9. 9.
    WHO. Guideline on HIV Self-Testing and Partner Notification [Internet]. 2016. http://apps.who.int/iris/bitstream/10665/251655/1/9789241549868-eng.pdf?ua=1. Accessed 8 May 2018.
  10. 10.
    Goyette M, Wamuti BM, Owuor M, Bukusi D, Maingi PM, Otieno FA, et al. Understanding barriers to scaling up HIV-assisted partner services in Kenya. AIDS Patient Care STDS. 2016;30(11):506–11.CrossRefGoogle Scholar
  11. 11.
    Kamanga G, Brown L, Jawati P, Chiwanda D, Nyirenda N. Maximizing HIV partner notification opportunities for index patients and their sexual partners in Malawi. Malawi Med J. 2015;27(4):140–4.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Dalal S, Johnson C, Fonner V, Kennedy CE, Siegfried N, Figueroa C, et al. Improving HIV test uptake and case finding with assisted partner notification services. AIDS Lond Engl. 2017;31(13):1867–76.CrossRefGoogle Scholar
  13. 13.
    Rutstein SE, Brown LB, Biddle AK, Wheeler SB, Kamanga G, Mmodzi P, et al. Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan. 2014;29(1):115–26.CrossRefGoogle Scholar
  14. 14.
    Olesen JS, Jespersen S, Da Silva ZJ, Rodrigues A, Erikstrup C, Aaby P, et al. HIV-2 continues to decrease, while HIV-1 is stabilizing in Guinea-Bissau. AIDS Lond Engl. 2018;32(9):1193–8.CrossRefGoogle Scholar
  15. 15.
    Jespersen S, Hønge BL, Oliveira I, Medina C, da Silva Te D, Correira FG, et al. Cohort Profile: the Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. Int J Epidemiol. 2015;44(3):756–63.CrossRefGoogle Scholar
  16. 16.
    Hønge BL, Jespersen S, Medina C, da Té D, da Silva ZJ, Lewin S, et al. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS ONE. 2014;9(6):99971.CrossRefGoogle Scholar
  17. 17.
    Oliveira I, Andersen A, Furtado A, Medina C, da Silva D, da Silva ZJ, et al. Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study. BMJ Open. 2012;2(6):e001587.CrossRefGoogle Scholar
  18. 18.
    Henley C, Forgwei G, Welty T, Golden M, Adimora A, Shields R, et al. Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries. Sex Transm Dis. 2013;40(12):909–14.CrossRefGoogle Scholar
  19. 19.
    Cherutich P, Golden MR, Wamuti B, Richardson BA, Asbjornsdottir KH, Otieno FA, et al. Assisted partner services for HIV in Kenya: a cluster randomised controlled trial. Lancet HIV. 2006;4(2):74–82.CrossRefGoogle Scholar
  20. 20.
    Brown LB, Miller WC, Kamanga G, Nyirenda N, Mmodzi P, Pettifor A, et al. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr. 2011;56(5):437–42.CrossRefGoogle Scholar
  21. 21.
    Rosenberg NE, Mtande TK, Saidi F, Stanley C, Jere E, Paile L, et al. Recruiting male partners for couple HIV testing and counselling in Malawi’s option B+ programme: an unblinded randomised controlled trial. Lancet HIV. 2015;2(11):e483–91.CrossRefGoogle Scholar
  22. 22.
    Kahabuka C, Plotkin M, Christensen A, Brown C, Njozi M, Kisendi R, et al. Addressing the First 90: a highly effective partner notification approach reaches previously undiagnosed sexual partners in Tanzania. AIDS Behav. 2017;21(8):2551–60.CrossRefGoogle Scholar
  23. 23.
    Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open. 2013;3(10):e003499.CrossRefGoogle Scholar
  24. 24.
    Jespersen S, Hønge BL, Oliveira I, Medina C, da Silva Té D, Correia FG, et al. Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborations. Bull World Health Organ. 2014;92(12):909–14.CrossRefGoogle Scholar
  25. 25.
    Nordentoft PB, Engell-Sørensen T, Jespersen S, Correia FG, Medina C, da Silva Té D, et al. Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau. Infection. 2017;45(2):187–97.CrossRefGoogle Scholar
  26. 26.
    Myers RS, Feldacker C, Cesar F, Paredes Z, Augusto G, Muluana C, et al. Acceptability and effectiveness of assisted human immunodeficiency virus partner services in Mozambique: results from a Pilot Program in a Public, Urban Clinic. Sex Transm Dis. 2016;43(11):690–5.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Tina Madsen
    • 1
    • 2
    Email author
  • Sanne Jespersen
    • 1
    • 2
  • Candida Medina
    • 3
  • David D. S. Té
    • 3
  • Christian Wejse
    • 1
    • 2
    • 4
  • Alex L. Laursen
    • 2
  • Bo L. Hønge
    • 1
    • 2
    • 5
  • for the Bissau HIV Cohort Study Group
  1. 1.Bandim Health Project, Indepth NetworkBissauGuinea-Bissau
  2. 2.Department of Infectious DiseasesAarhus University HospitalAarhusDenmark
  3. 3.National HIV ProgrammeMinistry of HealthBissauGuinea-Bissau
  4. 4.GloHAU, Center for Global Health, School of Public HealthAarhus UniversityAarhusDenmark
  5. 5.Department of Clinical ImmunologyAarhus University HospitalAarhusDenmark

Personalised recommendations